Prime Medicine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026

Published: 2026-05-07 12:21:21 ET PRME

Published on 05/07/2026 at 12:21 pm EDT

Prime Medicine, Inc. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported sales was USD 0.856 million compared to USD 1.45 million a year ago. Net loss was USD 49.12 million compared to USD 51.89 million a year ago.

Basic loss per share from continuing operations was USD 0.28 compared to USD 0.4 a year ago. Diluted loss per share from continuing operations was USD 0.28 compared to USD 0.4 a year ago.